High tariffs and trade policy instability have caused significant disruption in supply chain relationships and capital projects. Read More >>
Uncertainty around the timing, application, adjustment, and future of tariffs continues to raise many questions for the botanical industry.
There are plenty of opportunities for companies to develop unique, more personalized supplement formulations.
Suppliers and brands are working even more closely with each other to mitigate the effects of tariffs and uncertainty.
The scientific and business communities have recognized that decentralized trials broaden diverse participation and generate evidence that is more generalizable and real-world.
Brands that invest in transparency, scientific validation, and ethical sourcing will be best positioned to thrive in an evolving landscape.
Clinically demonstrated efficacy is still at the heart of everything we do, but science has to connect with real-world consumer needs.
